Fig. 4From: Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analysesForest Plot, Comparisons versus Placebo-12 from Network Meta-Analysis, Completion. Pairwise comparisons from the RE informative anlaysis are shown as summary odds ratios and 95% CrIs, focusing on comparisons of active comparators versus the control group of Placebo-12Â months in the network. Values >1 suggest greater likelihood of completion with the comparator, and regimens have been grouped according to duration. A league table of all summary comparisons from network meta-analysis is provided in Fig. 5 Back to article page